Mariner
RIGL icon

Mariner’s Rigel Pharmaceuticals RIGL Stock Holding History

Mariner’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$298K Buy
+6,185
New +$269K ﹤0.01% 2835

Other funds holding RIGL

American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
O'Shaughnessy Asset Management
O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Mariner's RIGL Position: Q3 2026 in Review

Mariner opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 6,185 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #2835 among its holdings.

108 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • Mariner held 6,185 shares of Rigel Pharmaceuticals worth $298K as of Q3 2026.
  • Rigel Pharmaceuticals was a new Mariner position in Q3 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q3 2026, its #2835 holding.
  • 108 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Mariner's 13F filing for Q3 2026, filed 12 Nov 2026.